KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Operating Margin (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Operating Margin readings, the most recent being 211.86% for Q4 2025.

  • On a quarterly basis, Operating Margin rose 2443.0% to 211.86% in Q4 2025 year-over-year; TTM through Dec 2025 was 185.29%, a 6125.0% increase, with the full-year FY2025 number at 185.29%, up 6125.0% from a year prior.
  • Operating Margin hit 211.86% in Q4 2025 for Ginkgo Bioworks Holdings, up from 231.78% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 34.37% in Q3 2021 to a low of 1134.55% in Q4 2021.
  • Median Operating Margin over the past 5 years was 235.59% (2022), compared with a mean of 347.75%.
  • Biggest five-year swings in Operating Margin: tumbled -96021bps in 2021 and later soared 89966bps in 2022.
  • Ginkgo Bioworks Holdings' Operating Margin stood at 1134.55% in 2021, then skyrocketed by 79bps to 234.89% in 2022, then tumbled by -118bps to 512.49% in 2023, then surged by 54bps to 236.29% in 2024, then grew by 10bps to 211.86% in 2025.
  • The last three reported values for Operating Margin were 211.86% (Q4 2025), 231.78% (Q3 2025), and 132.13% (Q2 2025) per Business Quant data.